SUBSCRIBE
SUBSCRIBE
News   Business

Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors

July 8, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
Internet Network Computer Security
Business
Novo hit with cybersecurity breach, urges vigilance among trial participants
June 12, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration showing finger pointing people to leave
Layoffs
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
June 11, 2026
 · 
1 min read
 · 
Angela Gabriel
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Kardigan stitches up $369M IPO plan
June 11, 2026
 · 
16 min read
 · 
Editorial Team
2D illustration showing scientists' hands editing a DNA strand
Funding
SonoThera bags $125M series B to advance safer gene therapies
June 11, 2026
 · 
2 min read
 · 
Tristan Manalac